Demonstrates ginger reduces BMI and body fat percentage in adults with type 2 diabetes, suggesting potential benefits for weight management.
Background and aims Evidence on the effects of ginger supplementation on anthropometric and body composition indices in adults with type 2 diabetes mellitus (T2DM) is inconsistent, and the certainty of this evidence has not been fully evaluated. This study aimed to systematically review and meta-analyze randomized controlled trials assessing these effects. Methods PubMed, Scopus, and Web of Science were searched until October 5, 2025. We used random-effects meta-analysis to find average differences with 95% CIs. Study quality and evidence certainty were checked with Cochrane RoB-2 tool and GRADE approach. Subgroup, meta-regression, sensitivity, and publication bias analyses were also done. Results This meta-analysis included 692 participants from 12 RCTs. Ginger supplementation significantly reduced body mass index ( BMI) (− 0.24 kg/m²; 95% CI: −0.48, − 0.00; p = 0.043) and body fat percentage (BF%) (− 1.44%; 95% CI: −2.49, − 0.38; p = 0.007), while no significant effects were observed on body weight (BW), waist circumference (WC), hip circumference (HC), or waist-to-hip ratio (WHR). Bias assessment showed 9 studies with some concerns, 1 low, and 2 high risk. Evidence quality was moderate for 4 outcomes (BMI, WHR, HC, BF%), low for WC, and high for BW. Conclusion Ginger reduced BMI and BF%, with no significant change in BW, WHR, HC, or WC. Trial registration This study was prospectively registered in PROSPERO (CRD420251162956).
No takes yet. Share an insight, caveat, or question.
Keshavarz et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: